End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 CNY | +1.54% | +3.27% | -18.97% |
Apr. 10 | Lanzhou Foci Pharmaceutical Chairman Resigns | MT |
Apr. 10 | Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Sales 2022 | 1.02B 141M | Sales 2023 | 1.16B 161M | Capitalization | 4.98B 691M |
---|---|---|---|---|---|
Net income 2022 | 106M 14.71M | Net income 2023 | 67M 9.3M | EV / Sales 2022 | 4.34 x |
Net cash position 2022 | 344M 47.69M | Net cash position 2023 | 353M 49.03M | EV / Sales 2023 | 3.98 x |
P/E ratio 2022 |
45
x | P/E ratio 2023 |
74.1
x | Employees | 1,353 |
Yield 2022 |
0.54% | Yield 2023 |
0.31% | Free-Float | 34.04% |
1 day | +1.54% | ||
1 week | +3.27% | ||
Current month | +1.54% | ||
1 month | -3.42% | ||
3 months | +22.86% | ||
6 months | -22.17% | ||
Current year | -18.97% |
Managers | Title | Age | Since |
---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 60 | 17-06-29 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 22-12-01 |
Li Jun Wu
BRD | Director/Board Member | 50 | 91-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 69 | 22-05-11 |
Xin Min Zhao
BRD | Director/Board Member | 54 | 20-01-01 |
Guo Lin Chai
PRN | Corporate Officer/Principal | 57 | 99-12-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 7.9 | +1.54% | 4,572,400 |
24-04-30 | 7.78 | +1.70% | 4,448,100 |
End-of-day quote Shenzhen S.E., May 05, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-18.97% | 549M | |
+43.35% | 6.11B | |
-15.99% | 4.35B | |
-6.35% | 3.19B | |
+4.87% | 3.15B | |
-0.53% | 2.51B | |
+53.07% | 1.98B | |
-3.63% | 1.74B | |
+2.76% | 1.63B | |
-8.02% | 1.6B |
- Stock Market
- Equities
- 002644 Stock